Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

from Neuro-Oncology: The Podcast · host Drs. Iyad Alnahhas, David Schiff, Ranjit Bindra

Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in Neuro-Oncology in October 2025.

Episode metadata supplied by the publisher feed · Published Feb 2, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

0:00 23:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 23 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on February 2, 2026.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!